Gold LS, Lebwohl MG, Bhatia N, Lin T, Pillai R. Long-Term Management of Moderate-to-Severe Plaque Psoriasis: Maintenance of Treatment Success Following Cessation of Fixed Combination Halobetasol Propionate 0.01% And Tazarotene 0.045% (HP/TAZ) Lotion. J of Skin [Internet]. 2019 Nov. 9 [cited 2024 Jul. 3];3:S31. Available from: https://jofskin.org/33014/index.php/skin/article/view/758